Abstract
Amyotrophic lateral sclerosis (ALS), a motor neuron disease, remains a clinical diagnosis with a diagnostic delay of over a year. Here we examine the possibility that interactions with an internet search engine could be used to help screen for ALS. We identified 285 anonymous Bing users whose queries indicated that they had been diagnosed with ALS and matched them to 1) 3276 control users and 2) 1814 users whose searches indicated they had ALS disease mimics. We tested whether the ALS group could be distinguished from controls and disease mimics based on search engine query data. Finally, we conducted a prospective validation from participants who provided access to their Bing search data. The model distinguished between the ALS group and controls with an area under the curve (AUC) of 0.81. Model scores for the ALS group differed from the disease mimics group (ranksum test, P<0.05 with Bonferrini correction). Mild cognitive impairment could not be distinguished from ALS (NS). In the prospective analysis, the model reached an AUC of 0.74. These results suggest that interactions with search engines could be used as a tool to assist in screening for ALS, to reduce diagnostic delay.
Competing Interest Statement
Elad Yom-Tov is an employee of Microsoft Research and James Berry has acted as a paid advisory panel member for MT Pharma of America and MT Pharma Holdings of America. The authors declare the following non-financial competing interests: Indu Navar is founder of Everything ALS, a non-profit advocacy and research organization. Ernest Fraenkel and James Berry are advisory board members to Everything ALS.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Microsoft Research institutional review board (IRB) gave ethical approval for the retrospective portion of our study. Advarra IRB gave ethical approval for the prospective portion of our study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Due to privacy considerations, data used in this study are confidential. The authors will make data available to researchers upon request, subject to Microsoft Research review and approval.
